LFMD

+ Watchlist + Portfolio

LifeMD, Inc.

Regulated industry Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.85
52-Week Range: $2.56 – $7.12
Market Cap: $132.22M
P/E (TTM): —
EPS (TTM): -0.51
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 16.41
PEG Ratio: —
Return on Equity: -515.90%
Return on Assets: -18.92%
Gross Margin: 87.50%
Operating Margin: -15.08%
Profit Margin: 0.10%
Current Ratio: 0.90
Debt/Equity: 0.76
Total Debt: $6.02M
Free Cash Flow: $-14.41M
Revenue Growth: -3.50%
Earnings Growth: —
Enterprise Value: $112.95M

LFMD Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$119.03M	$152.55M	$154.82M	$194.06M
Cost of Revenue	$18.67M	$18.90M	$21.44M	$27.71M
Gross Profit	$100.37M	$133.65M	$133.38M	$166.34M
Research & Development	$2.97M	$6.06M	$6.86M	$7.35M
Selling, General & Admin	$125.33M	$128.15M	$128.05M	$144.01M
Operating Expenses	$140.05M	$148.14M	$153.79M	$174.01M
Operating Income	-$39.69M	-$14.49M	-$20.40M	-$7.67M
EBITDA	-$35.92M	-$7.89M	-$14.21M	-$1.52M
Pretax Income	-$44.66M	-$17.41M	-$22.58M	-$10.19M
Income Tax	$360.70K	$428.00K	$598.00K	$45.72K
Net Income	-$45.54M	-$20.60M	-$21.41M	$14.35M
Diluted EPS	-1.57	-0.70	-0.53	0.25
Diluted Shares	30.98M	33.91M	41.20M	45.13M

LFMD Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$3.96M	$33.15M	$32.65M	$36.79M
Receivables	$2.83M	$5.28M	$10.46M	$9.31M
Inventory	$3.70M	$2.76M	$2.80M	$2.77M
Current Assets	$11.31M	$42.60M	$52.37M	$51.83M
Total Assets	$25.67M	$58.48M	$76.10M	$70.41M
Current Liabilities	$31.37M	$34.78M	$67.40M	$41.57M
Long-Term Debt	—	$17.93M	$9.89M	—
Total Debt	$4.13M	$18.93M	$24.93M	$6.32M
Total Liabilities	$32.97M	$52.91M	$83.65M	$47.25M
Retained Earnings	-$190.56M	-$214.27M	-$239.85M	-$228.60M
Shareholders' Equity	-$6.83M	$3.51M	-$9.08M	$23.16M
Working Capital	-$20.06M	$7.82M	-$15.03M	$10.26M

LFMD Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$22.94M	$8.82M	$17.51M	$8.28M
Capital Expenditure	-$12.89M	-$8.73M	-$8.20M	-$9.52M
Free Cash Flow	-$35.83M	$86.95K	$9.31M	-$1.24M
Depreciation & Amortisation	$3.77M	$6.60M	$6.19M	$7.31M
Stock-Based Compensation	$13.73M	$12.49M	$12.23M	$10.50M
Investing Cash Flow	-$13.91M	-$8.73M	-$11.54M	$6.91M
Financing Cash Flow	-$528.20K	$29.10M	-$4.12M	-$13.41M
Dividends Paid	-$3.11M	-$3.11M	-$3.11M	-$3.11M
Net Change in Cash	-$37.37M	$29.19M	$1.86M	$1.78M

LFMD Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$50.89M	$49.02M	$60.17M	$7.08M	$50.16M	$47.28M
Cost of Revenue	$8.14M	$6.84M	$7.41M	$4.23M	$5.93M	$5.28M
Gross Profit	$42.75M	$42.18M	$52.76M	$2.85M	$44.24M	$42.00M
Research & Development	$1.86M	$1.82M	$2.85M	-$920.04K	$1.80M	$1.79M
Selling, General & Admin	$36.61M	$36.59M	$46.06M	$5.01M	$45.05M	$41.68M
Operating Expenses	$43.93M	$44.53M	$54.73M	$9.07M	$53.17M	$49.13M
Operating Income	-$1.18M	-$2.35M	-$1.97M	-$6.22M	-$8.93M	-$7.13M
EBITDA	$509.69K	-$561.54K	$1.87M	-$6.22M	-$6.93M	-$5.09M
Pretax Income	-$1.65M	-$3.01M	-$3.39M	-$6.03M	-$8.87M	-$7.08M
Income Tax	$0.00	$0.00	$169.13K	-$123.41K	$0.00	$0.00
Net Income	-$183.78K	-$1.62M	-$3.81M	$19.96M	-$8.87M	-$7.08M
Diluted EPS	0.01	-0.05	-0.10	0.41	-0.20	-0.16
Diluted Shares	45.58M	44.40M	46.16M	46.77M	47.34M	47.79M

LFMD Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$34.39M	$36.23M	$23.79M	$36.79M	$34.48M	$25.14M
Receivables	$10.19M	$7.33M	$9.24M	$9.31M	$9.86M	$11.26M
Inventory	$2.97M	$3.25M	$3.43M	$2.77M	$3.18M	$2.96M
Current Assets	$49.97M	$49.03M	$41.09M	$51.83M	$51.70M	$42.08M
Total Assets	$73.61M	$73.56M	$65.98M	$70.41M	$70.12M	$59.89M
Current Liabilities	$60.90M	$63.53M	$56.66M	$41.57M	$49.59M	$46.61M
Long-Term Debt	$6.82M	$3.52M	—	—	—	—
Total Debt	$25.10M	$22.05M	$6.53M	$6.32M	$6.17M	$6.02M
Total Liabilities	$74.01M	$73.18M	$62.62M	$47.25M	$55.09M	$51.93M
Retained Earnings	-$235.64M	-$238.50M	-$247.79M	-$228.60M	-$238.25M	-$246.11M
Shareholders' Equity	-$2.33M	-$1.78M	$1.31M	$23.16M	$15.04M	$7.97M
Working Capital	-$10.93M	-$14.51M	-$15.58M	$10.26M	$2.11M	-$4.52M

LFMD Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$3.07M	$8.64M	-$147.14K	-$3.28M	$444.62K	-$6.93M
Capital Expenditure	-$2.00M	-$2.84M	-$5.32M	—	-$2.06M	-$1.63M
Free Cash Flow	$1.06M	$5.80M	-$5.47M	-$2.64M	-$1.61M	-$8.56M
Depreciation & Amortisation	$1.69M	$1.79M	$5.00M	-$1.16M	$2.00M	$2.04M
Stock-Based Compensation	$2.55M	$2.09M	$3.20M	$2.66M	$1.45M	$790.11K
Investing Cash Flow	-$2.87M	-$3.70M	-$3.59M	$17.07M	-$2.06M	-$1.63M
Financing Cash Flow	-$812.56K	-$3.10M	-$8.70M	-$788.56K	-$696.04K	-$776.56K
Dividends Paid	-$776.56K	-$776.56K	-$776.56K	-$776.56K	-$776.56K	-$776.56K
Net Change in Cash	-$611.51K	$1.83M	-$12.44M	$13.00M	—	—

Market Snapshot

About

LifeMD, Inc. is a direct-to-patient telehealth company providing virtual healthcare services across multiple specialties. The company offers prescription medications, diagnostics, and ongoing care management through digital platforms. LifeMD operates telehealth brands serving areas including primary care, men's health, women's health, dermatology, and weight management.